<DOC>
	<DOCNO>NCT00295945</DOCNO>
	<brief_summary>RATIONALE : Giving pain medication space wall spinal canal cover spinal cord give vein may help lessen pain caused cancer surgery . It yet know whether epidural analgesia effective patient-controlled analgesia control pain patient undergone surgery gynecologic cancer . PURPOSE : This randomized clinical trial study epidural analgesia see well work compare patient-controlled analgesia treat patient undergone surgery gynecologic cancer .</brief_summary>
	<brief_title>Epidural Analgesia Patient-Controlled Analgesia Treating Patients Who Have Undergone Surgery Gynecologic Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether gradual wean epidural opioid shorten duration postoperative ileus , without worsen pain control , patient undergo surgery gynecologic cancer . - Compare postoperative pain management patient treat perioperative epidural analgesia v patient control analgesia . - Compare time ambulation , return bowel function , readiness hospital discharge patient treat pain management intervention . - Compare incidence perioperative complication ( e.g. , bleeding , hypotension , thromboembolic event , pneumonia , wound infection , myocardial infection , death ) patient treat pain management intervention . OUTLINE : This partially randomize , double-blind , parallel-group study . Patients choose epidural analgesia patient control analgesia ( PCA ) perioperative pain management . Patients epidural contraindicate receive PCA . Patients assign 1 2 treatment group . Patients group 1 stratify accord bowel resection surgery ( yes v ) prior abdominal surgery ( yes v ) . - Group 1 ( epidural ) : Patients undergo placement thoracic epidural catheter follow abdominal/pelvic surgery . Patients begin epidural infusion ropivacaine hydrochloride fentanyl immediately surgery ( postoperative day 0 ) . Patients may also supplement patient control demand dose . The day surgery ( postoperative day 1 ) , patient randomize ( long adequate pain control ) 1 2 epidural management arm . - Arm I : Patients continue receive epidural infusion wean oral pain medication . - Arm II : Patients undergo daily wean fentanyl concentration epidural infusion . - Group 2 ( PCA ) : Patients begin PCA immediately undergo abdominal/pelvic surgery ( postoperative day 0 ) . Patients receive demand schedule hydromorphone IV wean oral pain medication . In group , Gynecologic Oncology pain service may make adjustment epidural infusion PCA optimal pain management patient wean oral pain medication . PROJECTED ACCRUAL : A total 224 patient accrue study .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Postoperative Complications</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Hydromorphone</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis gynecologic malignancy Scheduled undergo open abdominal/pelvic surgery ( i.e. , laparotomy ) gynecologic oncology service University California San Francisco Medical Center No fail epidural catheter ( patient choose epidural analgesia ) No lumbar epidural ( patient choose epidural analgesia ) PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>pain</keyword>
	<keyword>perioperative/postoperative complication</keyword>
	<keyword>stage III cervical cancer</keyword>
	<keyword>recurrent cervical cancer</keyword>
	<keyword>stage IB cervical cancer</keyword>
	<keyword>stage IIB cervical cancer</keyword>
	<keyword>stage IVB cervical cancer</keyword>
	<keyword>stage IA cervical cancer</keyword>
	<keyword>stage IIA cervical cancer</keyword>
	<keyword>stage IVA cervical cancer</keyword>
	<keyword>stage I endometrial carcinoma</keyword>
	<keyword>stage II endometrial carcinoma</keyword>
	<keyword>stage III endometrial carcinoma</keyword>
	<keyword>stage IV endometrial carcinoma</keyword>
	<keyword>recurrent endometrial carcinoma</keyword>
	<keyword>stage I uterine sarcoma</keyword>
	<keyword>stage II uterine sarcoma</keyword>
	<keyword>stage III uterine sarcoma</keyword>
	<keyword>stage IV uterine sarcoma</keyword>
	<keyword>recurrent uterine sarcoma</keyword>
	<keyword>ovarian sarcoma</keyword>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>recurrent ovarian germ cell tumor</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>stage IV ovarian germ cell tumor</keyword>
	<keyword>ovarian stromal cancer</keyword>
	<keyword>recurrent fallopian tube cancer</keyword>
	<keyword>stage IA fallopian tube cancer</keyword>
	<keyword>stage IB fallopian tube cancer</keyword>
	<keyword>stage IC fallopian tube cancer</keyword>
	<keyword>stage IIA fallopian tube cancer</keyword>
	<keyword>stage IIB fallopian tube cancer</keyword>
	<keyword>stage IIC fallopian tube cancer</keyword>
	<keyword>stage IIIA fallopian tube cancer</keyword>
	<keyword>stage IIIB fallopian tube cancer</keyword>
	<keyword>stage IIIC fallopian tube cancer</keyword>
	<keyword>stage IV fallopian tube cancer</keyword>
	<keyword>stage IA ovarian epithelial cancer</keyword>
	<keyword>stage IB ovarian epithelial cancer</keyword>
	<keyword>stage IC ovarian epithelial cancer</keyword>
	<keyword>stage IIA ovarian epithelial cancer</keyword>
	<keyword>stage IIB ovarian epithelial cancer</keyword>
	<keyword>stage IIC ovarian epithelial cancer</keyword>
	<keyword>stage IIIA ovarian epithelial cancer</keyword>
	<keyword>stage IIIB ovarian epithelial cancer</keyword>
	<keyword>stage IIIC ovarian epithelial cancer</keyword>
	<keyword>stage IA ovarian germ cell tumor</keyword>
	<keyword>stage IB ovarian germ cell tumor</keyword>
	<keyword>stage IC ovarian germ cell tumor</keyword>
	<keyword>stage IIA ovarian germ cell tumor</keyword>
	<keyword>stage IIB ovarian germ cell tumor</keyword>
	<keyword>stage IIC ovarian germ cell tumor</keyword>
	<keyword>stage IIIA ovarian germ cell tumor</keyword>
	<keyword>stage IIIB ovarian germ cell tumor</keyword>
	<keyword>stage IIIC ovarian germ cell tumor</keyword>
</DOC>